The Vanderbilt cardio-oncology program has been a leader in developing algorithms for the cardiovascular care of specific cancer patients and with specific cancer treatments.

Cardio-Oncology:   Overview

Cardio-Oncology: Novel platform for basic and clinical investigation (Circulation: 2015)

Cardio-Oncology: It takes two to translate (Science Translational Medicine: 2013)


Vanderbilt "ABCDE" Steps for Cardiovascular Health in Cancer Survivors

Cardio-Oncology and prostate Cancer:  ABCDE steps (Circulation: 2015)

Cardio-Oncology and breast Cancer:  ABCDE steps  (Circulation: 2014)


Cardiovascular Health in Hematological Malignancies

Cardio-Oncology and multiple myeloma  (JAMA Oncology: 2016)

Cardio-Oncology and multiple myeloma  (Circulation: 2016)

Cardio-Oncology and stem cell transplant  (2016)

Cardio-Oncology and CML  (chronic myeloid leukemia)  (Journal of Clinical Oncology: 2015)


Cardiovascular Health in Solid Malignancies

Cardio-Oncology and prostate cancer  (Circulation: 2016)

Cardio-Oncology and vascular disease (JACC: 2015)

Cardio-Oncology and breast cancer  (Circulation: 2014)

Cardio-Oncology and breast cancer survivorship (New England Journal of Medicine: 2013)

Cardio-Oncology and radiation  (European Heart Journal:  2013) 

Cardio-Oncology and VEGF Inhibitors  (Trends in Cardiovascular Medicine: 2013)

Cardio-Oncology and heart failure (Circulation Research: 2013)

Cardio-Oncology and VEGF Inhibitors: Reversible Cardiomyopathy (New England Journal of Medicine: 2011)


Cardio-Oncology - Guidelines and Fellowship Training

Cardio-Oncology and National Comprehensive Cancer Network (NCCN) Guidelines  (JNCCN: 2016)

Cardio-Oncology and  Fellowship Training  (JHF: 2016)